Hepatitis C infection and the risk of bacteremia in hemodialysis patients with tunneled vascular access catheters

Southern Medical Journal

Volumn 102, Issue 4, 2009, Pages 374-377

  Reddy, Shilpa ^a   Sullivan, Robert ^a   Zaiden, Robert ^a   De Mendoza, Victor Lopez ^a   Naik, Nimish ^a   Vega, Kenneth J ^a   Nahman, N Stanley ^a   Alexandraki, Irene ^a  

^a UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

Author keywords

Bacteremia; Hemodialysis; Hepatitis C; Tunneled catheters; Vascular access catheters

Indexed keywords

ADULT; ARTICLE; BACTEREMIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; INFECTION RISK; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; SEROLOGY; VASCULAR ACCESS DEVICE; VIRUS DETECTION; VIRUS LOAD;

ANALYSIS OF VARIANCE; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; FLORIDA; HEPATITIS C; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; VIRAL LOAD;

EID: 67651146539     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31819bc34c     Document Type: Article

References (15)

1. NKF-K/DOQI. Clinical Practice Guidelines for Vascular Access: Update 2006. III. Prevention of Complications: Infection. National Kidney Foundation, 2006.
2. Quarello F, Forneris G, Borca M, et al. Do central venous catheters have advantages over arteriovenous fistulas or grafts? J Nephrol 2006;19:265-279. (Pubitemid 46785537)
3. Sullivan R, Samuel V, Le C, et al. Hemodialysis catheter-related bacteremia. Am J Med Sci 2007;334:458-465.
4. Alexandraki I, Sullivan R, Zaiden R, et al. Blood culture isolates in hemodialysis vascular catheter-related bacteremia. Amer J Med Sci 2008;336:297-302.
5. Zaiden R, Sullivan R, Reddy S, et al. Cross-sectional study of the relationship between hepatitis C and bacteremia in hemodialysis patients with vascular catheters. J Am Soc Nephrol 2006;17:589A.
6. Reddy S, Zaiden R, Sullivan R, et al. Hepatitis C viral load and the risk of bacteremia in hemodialysis patients with vascular catheters. J Invest Med 2007;55:S308.
7. Germer JJ, Harmsen WS, Mandrekar JN, et al. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument. J Clin Microbiol 2005;43:293-298.
8. Saad TF. Central venous dialysis catheters: catheter-associated infection. Semin Dial 2001;14:446-451. (Pubitemid 33720890)
9. Lopez de Mendoza V, Reddy S, Sullivan R, et al. Natural history of vascular access catheters in hemodialysis patients. J Invest Med 2007;55:S272.
10. Ono Y, Watanabe T, Matsumoto K, et al. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood. J Infect Chemother 2004;10:200-207. (Pubitemid 39273437)
11. Jirillo E, Greco B, Caradonna L, et al. Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus (cHCV) infection. Immunopharmacol Immunotoxicol 1995;17:347-364.
12. Pavio N, Lai MM. The hepatitis C virus persistence: how to evade the immune system? J Biosci 2003;28:287-304. (Pubitemid 36512804)
13. Anderson KB, Guest JL, Rimland D. Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era: data from the HIV Atlanta VA Cohort Study. Clin Infect Dis 2004;39:1507-1513. (Pubitemid 39518216)
14. Miller MF, Haley C, Koziel MJ, et al. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 2005;41:713-720. (Pubitemid 41170361)
15. Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 2004;44:779-791. (Pubitemid 39445909)